Skip to content

Investigating the role of acceptance and commitment therapy in patients with substance use disorder

Investigating the role of acceptance and commitment therapy on reducing internalized stigma in patients with substance use disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211118053093N1
Enrollment
80
Registered
2021-12-04
Start date
2021-12-15
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance use disorder. Other psychoactive substance abuse

Interventions

Intervention 1: Intervention group: It consists of four groups of ten. Subjects receive their treatment in groups for three weeks including 12 hours in total (two two-hour sessions a week) and after o

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age 18-50 year Diagnosis of substance use disorder Informed consent

Exclusion criteria

Exclusion criteria: Medical disease Cognitive problems Psychiatric disorders

Design outcomes

Primary

MeasureTime frame
Internalized stigma score. Timepoint: Before the study and one week after the intervention. Method of measurement: Internalized Stigma Questionnaire that includes 28 Likert questions.

Secondary

MeasureTime frame
Quality of life score. Timepoint: Before the intervention and one week after the intervention. Method of measurement: World Health Organization Quality of Life Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Razeghian Jahromi

Shiraz University of Medical Sciences

leilarazeghian1366@gmail.com+98 71 3226 5702

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026